This is most likely why they have the reasoning behind

New Post Public Reply Private Reply Replies (1) Message Board
ohm20 Plotinus #144512
1,001
This is most likely why they have the reasoning behind Alzheimer's wrong.

Quote:
There is growing evidence that AD is a neuroinflammatory disease characterized by the increased presence of activated microglial cells and astrocytes in the brain (1). Both of these cells generate inflammatory mediators, such as complement proteins, cytokines, and chemokines in response to the Aβ peptide . Because peripheral blood monocytes can cross the blood-brain barrier (BBB) and undergo differentiation into microglial cells , we sought to determine the molecular basis of how peripheral blood monocytes/macrophages may accumulate in the AD brain in response to increased presence of amyloid peptide in circulation and in the brain of AD patients. In our previous studies , we showed that both the soluble (Aβ1–40) and fibrilar (Aβ1–42) form of amyloid peptides could induce the transmigration of human monocytes across cultured brain endothelial cell monolayer, a model of BBB.

Immunohistochemical studies show increased presence of chemokine macrophage inflammatory protein (MIP)-1β in a subpopulation of reactive astrocytes and MIP-1α in neurons of AD brain than those of controls. Moreover, their studies showed that chemokine receptor (CCR)3 and -5 are present on microglial cells of both control and AD brain but with an increased expression on reactive microglia in AD. Because CCR5 is expressed on monocytes and certain lymphocytes, and is activated by the β-chemokines [MIP-1β, MIP-1α, and regulated on activation normal T-expressed and presumably secreted (RANTES)] , we hypothesized that the increased expression of CCR5 on microglial cells or their precursors (monocytes/macrophages) could occur as a result of activation by Aβ peptides.
[url=https://journals.physiology.org/doi/full/10.1152/ajpcell.00461.2004
]https://journals.physiology.org/doi/full/10.1152/ajpcell.00461.2004
[/url]


Quote:
(1) We observed that Aβ peptides at pathophysiological concentrations (125 nM) increased CCR5 mRNA and cell surface protein expression. The cellular signaling involved activation of c-Raf, ERK-1/ERK-2, and c-Jun NH2-terminal kinase. Analysis of some transcription factors associated with CCR5 promoter revealed that Aβ increased DNA binding activity of Egr-1 and AP-1.
https://journals.physiology.org/doi/full/10.1...1.2004#R20


They say that amyloid peptides increase inflammatory factors and CCR5 expression. But that's putting the cart before the horse. As shown below activation of CCR5 and the accompanying inflammatory factors reduces the clearance of those tau and amyloid plaques.

The overexpression of that CCR5 does not even have to start in the brain or the central nervous system. Increased CCR5 can loosen the tight binds of the blood brain barrier to allow CCR5 expressing cells through to the brain. That exterior CCR5 could be caused by any number of factors, viruses, genetic mutations not directly related to CCR5, other disease states or simply ageing.

So what do we know about how high levels of CCR5 and inflammatory factors can damage the brain. We know overreactive microglia can damage the neuoronal sheath and kill the neurons themselves. We know it can lead to dendritic spine loss. They suppress cortical plasticity. They increase oxidative stress leading to a loss of synaptic function. Which of course leronlimab can reverse.

Quote:
We found that the microglial-derived CCL-3/-4/-5 bind and activate neuronal CCR5, which in turn promotes mTORC1 activation and disrupts autophagy and aggregate-prone protein clearance. CCR5 and its cognate chemokines are upregulated in the brains of pre-manifesting mouse models for Huntington’s disease (HD) and tauopathy, suggesting a pathological role of this microglia-neuronal axis in the early phases of these diseases. CCR5 upregulation is self-sustaining, as CCL5-CCR5 autophagy inhibition impairs CCR5 degradation itself. Finally, pharmacological or genetic inhibition of CCR5 rescues mTORC1 hyperactivation and autophagy dysfunction, which ameliorates HD and tau pathologies in mouse models.
[url=https://www.cell.com/neuron/fulltext/S0896-6273(23)00268-4
]https://www.cell.com/neuron/fulltext/S0896-6273(23)00268-4
[/url]


Quote:
Maraviroc significantly reduced HIV-induced amyloidogenesis, GSAP, phospho-Tau, neurodegeneration, BBB alterations, and leukocytes infiltration into the CNS. Maraviroc increased cellular Aβ efflux and transendothelial Aβ transport via LRP1 pathways. Thus, therapeutically targeting CCR5 could reduce viremia, preserve the BBB and neurons, increased brain Aβ efflux, and reduce AD-like neuropathologies.
https://pubmed.ncbi.nlm.nih.gov/34809709/

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 86

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Global-E Faces Fresh Scrutiny After Muted Quarterly Outlook

Updated Category News Views 39

A guidance bump that barely clears the curb can still wreck a stock. That is the unpleasant read-through from Global-E Online's third-quarter 2026 report: revenue guidance went higher, but not high enough to persuade investors that the business was pulling away from expectations. Shares fell after the release, and a securities-law investigation announced November 19 has...

Continue Reading
CMS Audit Proposal Reopens Medicare Advantage Risk

Updated Category News Views 104

A regulator just tossed a rusted anchor into managed care's earnings model. CMS's proposed Comprehensive Regulations to Uncover Suspicious Healthcare rule, dubbed CRUSH and numbered CMS-6098-P, puts Medicare Advantage risk-adjustment audits back at center stage. The headline nobody can casually wave away: audit findings from sampled enrollees could be extrapolated across...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 107

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Saturn and Tileward Put GPU Memory Back to Work Now

Updated Category News Views 31

GPU memory is the tollbooth nobody notices until the whole AI highway backs up. Saturn Cloud’s new partnership with Tileward goes straight at that constraint: use compressed open-model weights, free memory on hardware already installed, and turn that reclaimed capacity into more tokens that an operator can actually sell. It is not glamorous. It may be one of the more...

Continue Reading
PinnacleQM Makes Its Enterprise Case More Visible

Updated Category News Views 118

Six pages were never going to carry the weight of a complicated enterprise pitch. PinnacleQM has rebuilt its public face from a basic brochure into a library of more than 50 pages, putting its quality engineering, testing, automation and AI assurance work in clearer view for Australian technology and business buyers. This is not the sort of announcement that changes a...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 73

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
AV Access iDock B12 Chases the Growing Two-PC Desk Boom

Updated Category News Views 149

Cable spaghetti has become an oddly durable tax on anyone running a work laptop beside a gaming tower, and AV Access is taking a proper swing at it with the iDock B12. This is not some mystical new category; it is a KVM switch and docking station mashed together for a desk that has to serve two masters. Still, the company has aimed at the parts that usually get sacrificed...

Continue Reading
TCL CSOT's Oxide Leap Gives LCD a Sharper Fight Ahead

Updated Category News Views 64

Fifty-one point six is the number that makes this announcement worth chewing on. TCL CSOT says it has moved ultrahigh-mobility oxide technology into mass production on an 8.6-generation line, clearing the 50 cm² V?¹ s?¹ threshold that has largely belonged to lab-talk and presentation slides. For display people, that is not decorative science. It could change the old...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 55

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading

Top 5 Most Recently Viewed Articles

Cathie Wood's Bold Investment in BitMine's Ethereum Strategy

Updated Category News Views 200

ARK Invest's Strategic Move ARK Invest, under the dynamic leadership of Cathie Wood, has taken a significant step by investing in BitMine Immersion Technologies Inc. The firm acquired nearly 4.8 million shares of BitMine, valued at an impressive $182 million through multiple ARK funds. Focus on Ethereum Acquisition This investment reflects BitMine's ambitious plan to...

Continue Reading
23andMe Advances Chapter 11 Plans with Court Approvals

Updated Category News Views 421

23andMe Secures Court Approval in Chapter 11 Process In a significant development, 23andMe Holding Co. (“23andMe” or the “Company”) (Nasdaq: ME), recognized for its innovative approach in genetics and biotechnology, has received critical approvals from a Bankruptcy Court related to its Chapter 11 petitions. These petitions were filed, propelling the Company into a...

Continue Reading
Insights into Archer Aviation's Stock and Market Movements

Updated Category News Views 190

Understanding Archer Aviation's Stock Dynamics In a notable shift, investors with significant capital are displaying a bullish outlook on Archer Aviation. This uptrend is primarily highlighted by the option trading activities surrounding the company. Recent Option Trading Insights The latest data reveals that there have been 20 trades observed within Archer Aviation's...

Continue Reading
PACT Capital Partners Sets New Standards in Investment Strategies

Updated Category News Views 471

PACT Capital Partners Launches as an Independent Investment Firm PACT Capital LLC, known as PACT Capital Partners, has officially launched as a pioneering independent investment firm focused on empowering middle-market alternative asset managers. With significant backing from major players, the firm aims to carve a niche in the competitive investment landscape. Strategic...

Continue Reading
Bakery Mixes Forecast 2026-2036: Growth and Trends

Updated Category News Views 61

Standardization Taking Center Stage in Bakery Mixes Imagine a bustling bakery floor, with the smell of fresh bread wafting through the air. Yet behind the scenes lies a streamlined operation driven by pre-formulated mixes, which is exactly where the global bakery mixes market finds its muscle these days. Valued at $6.5 billion in 2025, the market has its sights set on...

Continue Reading